Aemetis (NASDAQ:AMTX – Get Rating) announced its earnings results on Thursday. The specialty chemicals company reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.44) by $0.41, Fidelity Earnings reports. During the same quarter in the prior year, the firm earned ($0.38) EPS.
Aemetis Stock Up 24.8 %
Shares of AMTX opened at $10.18 on Friday. Aemetis has a 12-month low of $4.45 and a 12-month high of $23.33. The business has a 50-day simple moving average of $6.33 and a two-hundred day simple moving average of $9.05. The stock has a market cap of $352.02 million, a PE ratio of -9.01 and a beta of 0.62.
Analyst Upgrades and Downgrades
Several analysts recently weighed in on the company. Credit Suisse Group dropped their price objective on Aemetis from $35.00 to $27.00 and set an “outperform” rating for the company in a research report on Monday, June 13th. Ascendiant Capital Markets downgraded Aemetis to an “outperform” rating and set a $33.00 price objective for the company. in a research report on Monday, June 6th. One investment analyst has rated the stock with a sell rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $31.00.
Hedge Funds Weigh In On Aemetis
Aemetis, Inc operates as a renewable natural gas and renewable fuels company in North America and India. It operates through three segments: California Ethanol, Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products.
- Get a free copy of the StockNews.com research report on Aemetis (AMTX)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.